They tell you to use the code if the patient is using an injectable non-insulin antidiabetic drug such as Trulicity or Victoza and any other injectable GLP-1 receptor agonist, in addition to insulin, coded with Z79.4 ( Long term (current) use of insulin ), or oral diabetes drugs, such as metformin, coded to Z79.84 ( Long term (current) use of oral hypoglycemic drugs )
That said, when we attempt to pharmacologically interfere with, preserve, or augment the bodys innate physiological processes, there are bound to be side effects and adverse events
Do not forget to read, What Is Type 5 Diabetes
With digestion moving at a slower pace, even a normal-sized meal can feel heavy and linger longer than youd expect
Richard DiMarchi, one of the pioneers of GLP-1 drugs, argues that the degree which they have helped to manage excess body weight compares with the historic breakthroughs in the management of excess blood pressure, excess lipids and excess glucose
The three recommended injection site areas are: Abdomen: At least two inches away from the belly button, avoiding the waistline Front or outer thigh: Midway between knee and hip Outer upper arm: Best if someone else administers the injection Research shows that absorption across these three sites is similar when injections reach the subcutaneous layer properly, though some data suggest thigh absorption may be marginally slower in the first hours after injection
